Skip to content

PROBELPHARMA

Active
Private limited companyfounded 200026 yrs activeGulpen 327, 4852 Plombières, BelgiumKBO/BCE: BE 0471.439.893
Summary

PROBELPHARMA has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €120,358 and a net result of -€3,556. Equity is shrinking by ~5.5% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 1.0% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability34▼-1
Solvency66▼-1
Growth58=
Track record100
Bankruptcy probability, 12 months
1.0% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €6,000 at 30 days acceptable
Liquidity short (current ratio 0.03 against 0.05 in 2024; short-term debt: 58.9% and cash: 1.9% of total assets), and 58.9% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 26 years 0 30 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year -€3,556
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-06-2026, 35 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
35 d early
2024
61 d late
2023
37 d early
2022
26 d early
2021
37 d early
2020
29 d early
2019
35 d late
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 7 accounts on average 10 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 26 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 15 March 2000, PROBELPHARMA was incorporated.1 Total assets went from EUR 355,332 in 2018 to EUR 293,072 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€3,556▼ 5.1%
2024 · -€3,384
Working capital
-€166,702▼ 2.2%
2024 · -€163,147
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result-€2,816▲ 65.9%-€9,570▼ 240%-€9,792▼ 2.3%-€3,265▲ 66.7%-€3,881▼ 18.9%
Net result-€3,774▲ 57.3%-€10,837▼ 187%-€8,904▲ 17.8%-€3,384▲ 62.0%-€3,556▼ 5.1%
Equity€147,039▼ 2.5%€136,202▼ 7.4%€127,298▼ 6.5%€123,914▼ 2.7%€120,358▼ 2.9%
Total assets€319,329▼ 1.0%€308,347▼ 3.4%€306,780▼ 0.5%€296,278▼ 3.4%€293,072▼ 1.1%
Debt€172,289▲ 0.3%€172,145▼ 0.1%€179,482▲ 4.3%€172,364▼ 4.0%€172,714▲ 0.2%
Working capital-€138,534▼ 2.8%-€149,323▼ 7.8%-€159,714▼ 7.0%-€163,147▼ 2.1%-€166,702▼ 2.2%
Result per fiscal year
Operating resultNet result
-€15,000-€10,000-€5,000€0Operating result 2021: -€2,816-€2,816Net result 2021: -€3,774-€3,774Operating result 2022: -€9,570-€9,570Net result 2022: -€10,837-€10,837Operating result 2023: -€9,792-€9,792Net result 2023: -€8,904-€8,904Operating result 2024: -€3,265-€3,265Net result 2024: -€3,384-€3,384Operating result 2025: -€3,881-€3,881Net result 2025: -€3,556-€3,55620212022202320242025-€10,000-€7,500-€5,000-€2,500€0Operating result 2023: -€9,792-€9,790Net result 2023: -€8,904-€8,900Operating result 2024: -€3,265-€3,260Net result 2024: -€3,384-€3,380Operating result 2025: -€3,881-€3,880Net result 2025: -€3,556-€3,560202320242025
The operating result stays negative: a loss of €3,881 in 2025 against €3,265 in 2024; the loss grows.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €293,072
Fixed assets €287,060 =
Current assets €6,012 ▼ 34.8%
Equity and liabilities €293,072
Equity €120,358 ▼ 2.9%
Debt €172,714 ▲ 0.2%
Debt's share of the balance-sheet total rises from 58.2% to 58.9%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
Current ratio
0.03▼
2024 · 0.05
Debt to equity
1.44▲
2024 · 1.39
ROE
-3.0%▼
2024 · -2.7%
ROA
-1.2%▼
2024 · -1.1%
Debt ≤ 1 year
€172,714▲
2024 · €172,364
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 31 lines
Balance sheet Code20242025
Assets
Total assets20/58€296,278€293,072▼
Fixed assets21/28€287,060€287,060=
Financial fixed assets28€287,060€287,060=
Current assets29/58€9,217€6,012▼
Amounts receivable within one year40/41€498€498=
Other amounts receivable41€498€498=
Cash at bank and in hand54/58€8,719€5,514▼
Equity and liabilities
Total equity and liabilities10/49€296,278€293,072▼
Equity10/15€123,914€120,358▼
Contributions10/11€16,481€16,481=
Reserves13€3,992€3,992=
Distributable reserves133€3,992€3,992=
Profit (loss) carried forward14€103,440€99,884▼
Amounts payable17/49€172,364€172,714▲
Amounts payable within one year42/48€172,364€172,714▲
Trade debts44€390€740▲
Suppliers440/4€390€740▲
Other amounts payable47/48€171,974€171,974=
Accrued charges and deferred income492/3€0-
Income statement Code20242025
Other operating charges640/8€0-
Gross operating margin9900-€3,265-€3,881▼
Operating profit (loss)9901-€3,265-€3,881▼
Financial income75/76B€1,005€1,504▲
Recurring financial income75€1,005€1,504▲
Financial charges65/66B€1,124€1,179▲
Recurring financial charges65€1,124€1,179▲
Profit (loss) for the period before taxes9903-€3,384-€3,556▼
Profit (loss) for the period9904-€3,384-€3,556▼
Profit (loss) for the period to be appropriated9905-€3,384-€3,556▼
Appropriation of the result
Profit (loss) to be appropriated9906€103,440€99,884▼
Profit (loss) brought forward from the previous period14P€106,825€103,440▼

The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Other operating charges640/8-€150€6,309€0--
Gross operating margin9900-€2,816-€9,420-€3,483-€3,265-€3,881▼ 18.9%
Operating profit (loss)9901-€2,816-€9,570-€9,792-€3,265-€3,881▼ 18.9%
Financial income75/76B€466€0€2,112€1,005€1,504▲ 49.7%
Recurring financial income75€466€0€2,112€1,005€1,504▲ 49.7%
Financial charges65/66B€1,423€1,268€1,223€1,124€1,179▲ 4.9%
Recurring financial charges65€1,423€1,268€1,223€1,124€1,179▲ 4.9%
Profit (loss) for the period before taxes9903-€3,774-€10,837-€8,904-€3,384-€3,556▼ 5.1%
Profit (loss) for the period9904-€3,774-€10,837-€8,904-€3,384-€3,556▼ 5.1%
Profit (loss) for the period to be appropriated9905-€3,774-€10,837-€8,904-€3,384-€3,556▼ 5.1%
Line20212022202320242025Change
Assets
Total assets20/58€319,329€308,347€306,780€296,278€293,072▼ 1.1%
Fixed assets21/28€285,573€285,573€287,060€287,060€287,060=
Financial fixed assets28€285,573€285,573€287,060€287,060€287,060=
Current assets29/58€33,755€22,774€19,719€9,217€6,012▼ 34.8%
Amounts receivable within one year40/41€498€498€498€498€498=
Other amounts receivable41€498€498€498€498€498=
Cash at bank and in hand54/58€33,258€22,276€19,222€8,719€5,514▼ 36.8%
Equity and liabilities
Total equity and liabilities10/49€319,329€308,347€306,780€296,278€293,072▼ 1.1%
Equity10/15€147,039€136,202€127,298€123,914€120,358▼ 2.9%
Contributions10/11€16,481€16,481€16,481€16,481€16,481=
Reserves13€3,992€3,992€3,992€3,992€3,992=
Non-distributable reserves130/1€0-----
Reserves not available under the articles1311€0-----
Distributable reserves133€3,992€3,992€3,992€3,992€3,992=
Profit (loss) carried forward14€126,566€115,728€106,825€103,440€99,884▼ 3.4%
Amounts payable17/49€172,289€172,145€179,482€172,364€172,714▲ 0.2%
Amounts payable within one year42/48€172,289€172,097€179,434€172,364€172,714▲ 0.2%
Trade debts44€540€348€1,014€390€740▲ 89.9%
Suppliers440/4€540€348€1,014€390€740▲ 89.9%
Other amounts payable47/48€171,749€171,749€178,419€171,974€171,974=
Accrued charges and deferred income492/3-€48€48€0--
Line20212022202320242025Change
Profit (loss) for the period9904-€3,774-€10,837-€8,904-€3,384-€3,556▼ 5.1%
Operating cash flow (approximation)-€3,774-€10,837-€8,904-€3,384-€3,556▼ 5.1%
Investment in fixed assets (approximation)-€0-€1,487€0€0-
Change in cash--€10,982-€3,054-€10,502-€3,206▲ 69.5%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
26-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
30-09
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 61 days late
2024
24-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
05-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
24-06
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
02-07
NBB filing Annual accounts filed
fiscal year 2020 · full schema
2020
04-09
NBB filing Annual accounts filed
fiscal year 2019 · full schema · 35 days late
2019
31-12
Financial Weakest financial yearnet -€22,940
Net result drops to -€22,940, the lowest in the series; recovery starts the following year.
07-06
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
13-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
10-06
NBB filing Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts

We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Plombières · 1 establishment unit since 2000
seat establishment approximate The establishment unit on the map
Ground area
2.7 ha
Building footprint
242 m²
Volume, LiDAR
997 m³
2 parcels, Flanders, Wallonia · tallest building 10.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Schurhoven 3149, 3800 Sint-Truiden
Insurance, reinsurance and pension funding, except compulsory social security
since 20002.116.068.460
2 parcels
Flanders 1 (50%) Wallonia 1 (50%)
Parcel (capakey) Region Area Buildings Height / fl.
63037B0348/00F000 Wallonia 2.7 ha 1 · 81 m² -
71352D0679/00P000indicative
ProtectedTownscape or village viewBegijnhof: franjeSource ↗
Flanders 268 m² 1 · 161 m² 10.6 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage: expect extra rules on renovation or sale.

Structure & network

Owners and holdings

1 holding

Owners 0

The accounts to 31-12-2024 list no shareholders, and no other source names one.

Holdings 1

According to the 2024 annual accounts of PROBELPHARMA and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Identification & contact

Identification
Legal formPrivate limited company
Founded15-03-2000
Fiscal year end31-12
E-invoicing
Not found in the Peppol register

No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.

What can you do?

Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.

If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if electronically, with their agreement on a secure alternative. That invoice is valid; the customer risks a penalty. FPS Finance

If you follow this company, Checked tells you the day it appears in the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.